Biophysical cartography of the native and human-engineered antibody landscapes quantifies the plasticity of antibody developability
Designing effective monoclonal antibody (mAb) therapeutics faces a multi-parameter
optimization challenge known as “developability”, which reflects an antibody's ability to …
optimization challenge known as “developability”, which reflects an antibody's ability to …
Biophysical cartography of the native and human-engineered antibody landscapes quantifies the plasticity of antibody developability
Designing effective monoclonal antibody (mAb) therapeutics face a significant challenge
known as" developability", which reflects an antibody's ability to progress through …
known as" developability", which reflects an antibody's ability to progress through …
Cartography of the developability landscapes of native and human-engineered antibodies
Design: ing effective monoclonal antibody (mAb) therapeutics face a significant challenge
known as “developability”, which reflects an antibody's ability to progress through …
known as “developability”, which reflects an antibody's ability to progress through …